T

Theraclone Sciences

2 employees

Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2004

Funding rounds raised

Total raised

$29M

from 17 investors over 17 rounds

T

Theraclone Sciences raised $8M on March 25, 2013

Investors: Versant Ventures, MPM Capital, ARCH Venture Partners and Canaan

T

Theraclone Sciences raised $6M on March 25, 2013

Investors: MidCap Financial

T

Theraclone Sciences raised $11M on September 8, 2011

Investors: Canaan, HealthCare Ventures LLC, ARCH Venture Partners and MPM Capital

T

Theraclone Sciences raised $1.5M on March 17, 2010

Investors: Canaan, ARCH Venture Partners and MPM Capital

T

Theraclone Sciences raised $29M on March 19, 2007

Investors: ARCH Venture Partners, HealthCare Ventures LLC, MPM Capital and Canaan

T

Theraclone Sciences raised $4.6M on March 3, 2006

Investors: ARCH Venture Partners

FAQ